These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17343717)

  • 1. Defibrillator therapies in hypertrophic cardiomyopathy: too many swings at bad pitches?
    Kim SS; Knight BP
    J Cardiovasc Electrophysiol; 2007 May; 18(5):488-9. PubMed ID: 17343717
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy.
    Cha YM; Gersh BJ; Maron BJ; Boriani G; Spirito P; Hodge DO; Weivoda PL; Trusty JM; Friedman PA; Hammill SC; Rea RF; Shen WK
    J Cardiovasc Electrophysiol; 2007 May; 18(5):483-7. PubMed ID: 17343723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter defibrillators in children:
    Frias PA
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):77-8. PubMed ID: 15028077
    [No Abstract]   [Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillators in patients with Chagas heart disease: misperceptions, many questions and the urgent need for a randomized clinical trial.
    Rassi A
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1241-3. PubMed ID: 17971129
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
    Cardinalli-Neto A; Bestetti RB; Cordeiro JA
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):E34-5. PubMed ID: 18298517
    [No Abstract]   [Full Text] [Related]  

  • 6. Clustering of ventricular arrhythmias: a therapeutic opportunity or strictly a marker of poor prognosis?
    Curtis AB
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1307-9. PubMed ID: 17034407
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary prophylaxis of sudden death in hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and dilated cardiomyopathy.
    Klein GJ; Krahn AD; Skanes AC; Yee R; Gula LJ
    J Cardiovasc Electrophysiol; 2005 Sep; 16 Suppl 1():S28-34. PubMed ID: 16138882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of syncope in patients with hypertrophic cardiomyopathy.
    Haghjoo M; Faghfurian B; Taherpour M; Fazelifar AF; Mohammadzadeh S; Alizadeh A; Sadr-Ameli MA
    Pacing Clin Electrophysiol; 2009 May; 32(5):642-7. PubMed ID: 19422586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
    Cardinalli-Neto A; Bestetti RB; Cordeiro JA; Rodrigues VC
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1236-40. PubMed ID: 17900257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular tachycardia storm after initiation of biventricular pacing: incidence, clinical characteristics, management, and outcome.
    Nayak HM; Verdino RJ; Russo AM; Gerstenfeld EP; Hsia HH; Lin D; Dixit S; Cooper JM; Callans DJ; Marchlinski FE
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):708-15. PubMed ID: 18363690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dl-sotalol on mortality and recurrence of ventricular tachyarrhythmias: ischemic compared to nonischemic cardiomyopathy.
    Furushima H; Chinushi M; Okamura K; Komura S; Tanabe Y; Sato A; Izumi D; Aizawa Y
    Pacing Clin Electrophysiol; 2007 Sep; 30(9):1136-41. PubMed ID: 17725758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of appropriate defibrillator shock 3 hours and 20 minutes following implantation in a patient with hypertrophic cardiomyopathy.
    Almquist AK; Hanna CA; Haas TS; Maron BJ
    J Cardiovasc Electrophysiol; 2008 Mar; 19(3):319-22. PubMed ID: 17764447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful therapeutic hypothermia in patients with hypertrophic cardiomyopathy.
    Maron BJ; Maron MS; Maron BA; Haas TS; Altman RK; Smalley SJ; Doerer JJ; Link MS; Mooney MR
    J Am Coll Cardiol; 2011 Jun; 57(24):2454-6. PubMed ID: 21640539
    [No Abstract]   [Full Text] [Related]  

  • 18. It is time to check estimated glomerular filtration rate level in implantable cardioverter-defibrillator patients.
    Zareba W
    Europace; 2009 Nov; 11(11):1415-6. PubMed ID: 19880405
    [No Abstract]   [Full Text] [Related]  

  • 19. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
    Stockburger M; Celebi O; Krebs A; Knaus T; Nitardy A; Habedank D; Dietz R
    Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive approach to management of ventricular arrhythmias.
    Kusumoto F
    Cardiol Clin; 2008 Aug; 26(3):481-96, vii. PubMed ID: 18538192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.